A new trading day began on Tuesday, with Gossamer Bio Inc (NASDAQ: GOSS) stock price down -4.15% from the previous day of trading, before settling in for the closing price of $0.96. GOSS’s price has ranged from $0.50 to $1.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 76.06%. With a float of $174.03 million, this company’s outstanding shares have now reached $226.60 million.
In an organization with 135 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 97.34%, operating margin of -56.03%, and the pretax margin is -60.96%.
Gossamer Bio Inc (GOSS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 23.20%, while institutional ownership is 57.01%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.06% per share during the next fiscal year.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Here are Gossamer Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.87 million. That was inferior than the volume of 1.19 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 34.82%. Additionally, its Average True Range was 0.09.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 50.22%, which indicates a significant increase from 30.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.84% in the past 14 days, which was higher than the 72.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8366, while its 200-day Moving Average is $0.8590. However, in the short run, Gossamer Bio Inc’s stock first resistance to watch stands at $0.9647. Second resistance stands at $1.0073. The third major resistance level sits at $1.0347. If the price goes on to break the first support level at $0.8947, it is likely to go to the next support level at $0.8673. The third support level lies at $0.8247 if the price breaches the second support level.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
With a market capitalization of 208.93 million, the company has a total of 226,604K Shares Outstanding. Currently, annual sales are 0 K while annual income is -179,820 K. The company’s previous quarter sales were 9,480 K while its latest quarter income was -30,800 K.
